ArmandoPérez dePrado (@foroic) 's Twitter Profile
ArmandoPérez dePrado

@foroic

Interventional cardiologist, science & technology geek. Linked to @foroepic (open discussion forum on interventional cardiology) @fundacionepic @fundepicmedia

ID: 207930447

linkhttps://www.linkedin.com/in/cardioconsult/ calendar_today26-10-2010 09:44:18

3,3K Tweet

1,1K Takipçi

402 Takip Edilen

REC Publications (@revespcardiol) 's Twitter Profile Photo

Plaque modification and impact on the microcirculation territory after drug-coated balloon angioplasty. The PLAMI study design #recintervcardiol Francisco Ten Morro Luis Martinez Dolz Jose Luis Diez Gil Jorge Sanz Sánchez recintervcardiol.org/en/original-ar…

Plaque modification and impact on the microcirculation territory after drug-coated balloon angioplasty. The PLAMI study design #recintervcardiol  <a href="/francisco_morro/">Francisco Ten Morro</a> <a href="/luismdolz/">Luis Martinez Dolz</a> <a href="/JL_10_HILL/">Jose Luis Diez Gil</a> <a href="/sjorge4/">Jorge Sanz Sánchez</a> recintervcardiol.org/en/original-ar…
ArmandoPérez dePrado (@foroic) 's Twitter Profile Photo

Discordance between fractional flow reserve and nonhyperemic index with a fiber-optic pressure wire. READI EPIC-14 recintervcardiol.org/en/ischemic-he… #recintervcardiol vía REC Publications

ArmandoPérez dePrado (@foroic) 's Twitter Profile Photo

Safety and efficacy of the Essential Pro paclitaxel drug-eluting balloon for the treatment of coronary in-stent restenosis recintervcardiol.org/en/ischemic-he… #recintervcardiol vía REC Publications

ArmandoPérez dePrado (@foroic) 's Twitter Profile Photo

Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory recintervcardiol.org/en/review-arti… #recintervcardiol vía REC Publications

ArmandoPérez dePrado (@foroic) 's Twitter Profile Photo

Muy interesante análisis. Atención al gap entre lo que uno piensa que hace mal y lo que hace mal en realidad! Esto es el reconocimiento de los pecados. Luego ya, si eso, viene la contrición y propósito de la enmienda …

CNIC (@cnic_cardio) 's Twitter Profile Photo

🔊 Don't miss the date! Dr. Héctor Bueno, from CNIC, will receive the ESC President’s Awards at the Inaugural Session of #ESCCongress in London. Congratulations! 🏆 📅 August 30 ⏰ From 17:30 to 18:30 PM BST 📍London ➡️esc365.escardio.org/ESC-Congress/s… #CardioTwitter

🔊 Don't miss the date! 
Dr. Héctor Bueno, from <a href="/CNIC_CARDIO/">CNIC</a>, will receive the ESC President’s Awards at the Inaugural Session of #ESCCongress in London. Congratulations! 🏆

📅 August 30
⏰ From 17:30 to 18:30 PM BST
📍London
➡️esc365.escardio.org/ESC-Congress/s… 

#CardioTwitter
Stephan Achenbach (@steph_achenbach) 's Twitter Profile Photo

New ESC Chronic Coronary Syndrome Guidelines just out. For LM stenoses w/ low Syntax Score, both surgery and PCI - as long as full revasc is possible - have Class IA recommendation. Image-guided PCI has Class IA for LM / bifu / long lesions #Cardiotwitter European Society of Cardiology #ESCCongress

New ESC Chronic Coronary Syndrome Guidelines just out. For LM stenoses w/ low Syntax Score, both surgery and PCI - as long as full revasc is possible - have Class IA recommendation. Image-guided PCI has Class IA for LM / bifu / long lesions
#Cardiotwitter <a href="/escardio/">European Society of Cardiology</a> #ESCCongress
Felipe Díez del Hoyo (@felipediezhoyo) 's Twitter Profile Photo

📌 Nueva evidencia en #ESCCongress a favor de la terapia borde-a-borde (TEER) en la IM funcional 🫀 📝 TEER+💊 ⬇️ ingresos por IC y ☠️ CV 36% versus 💊 📝 TEER+💊 se asocia a una importante mejoría clínica en CF 📝 Misma ☠️ 🎯 Se incluyó IM severa, ¡pero también moderada!

📌 Nueva evidencia en #ESCCongress a favor de la terapia borde-a-borde (TEER) en la IM funcional 🫀
 
📝 TEER+💊  ⬇️ ingresos por IC y ☠️ CV 36% versus 💊
📝 TEER+💊  se asocia a una importante mejoría clínica en CF
📝 Misma ☠️ 

🎯 Se incluyó IM severa, ¡pero también moderada!
NEJM (@nejm) 's Twitter Profile Photo

In the NOTION-3 trial of percutaneous coronary intervention or conservative treatment in patients undergoing TAVI, PCI was associated with a lower risk of a composite of death, MI, or urgent revascularization at a median of 2 years. Full results: nej.md/3AH5WJo #ESCardio

In the NOTION-3 trial of percutaneous coronary intervention or conservative treatment in patients undergoing TAVI, PCI was associated with a lower risk of a composite of death, MI, or urgent revascularization at a median of 2 years. Full results: nej.md/3AH5WJo #ESCardio
Enrique Santas (@santasenrique) 's Twitter Profile Photo

OCEANIC-AF #ESCCongress @nejm Asundexian (inhibidor del F XIA) vs apixabán en 👥 con #fibrilacionauricular Estudio detenido 🛑 precozmente por aumento significativo del riesgo de ictus/ES 🧠 con asundexian vs apixaban (HR, 3.79; IC 2.46-5.83) Menos eventos de sangrado 🩸

OCEANIC-AF #ESCCongress @nejm

Asundexian (inhibidor del F XIA) vs apixabán en 👥 con #fibrilacionauricular 

Estudio detenido 🛑 precozmente por aumento significativo del riesgo de ictus/ES 🧠 con asundexian vs apixaban (HR, 3.79;  IC 2.46-5.83) 

Menos eventos de sangrado 🩸
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

In STEMI pts > 75 years with MVD, complete revascularization reduces ischemic events (death, MI, or ID-revascularization) up to 4 years vs. culprit-only revasc, but primary endpoint reduction wanes in long-term follow-up.

In STEMI pts &gt; 75 years with MVD, complete revascularization reduces ischemic events (death, MI, or ID-revascularization) up to 4 years vs. culprit-only revasc, but primary endpoint reduction wanes in long-term follow-up.
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Too fast or not too fast before cardiac cath? SCOFF trial shows no fasting was superior to fasting for primary endpoint of aspiration pneumonia, hypotension, hyperglycemia, hypoglycemia (19.1% vs. 12.0%).

Too fast or not too fast before cardiac cath? SCOFF trial shows no fasting was superior to fasting for primary endpoint of aspiration pneumonia, hypotension, hyperglycemia, hypoglycemia (19.1% vs. 12.0%).
Radcliffe Cardiology (@radcliffecardio) 's Twitter Profile Photo

🗓️ Join us for the #LAACSummit on 24, 25 & 26 September for the latest clinical evidence of Left Atrial Appendage Closure (LAAC) therapy! 🔗 Secure your free spot now 👉 ow.ly/qmXH50Tcj4M Esteemed experts deliver an exciting three day programme on: 🫀 Day 1: Stroke

🗓️ Join us for the #LAACSummit on 24, 25 &amp; 26 September for the latest clinical evidence of Left Atrial Appendage Closure (LAAC) therapy! 🔗 Secure your free spot now 👉 ow.ly/qmXH50Tcj4M

Esteemed experts deliver an exciting three day programme on: 
🫀 Day 1: Stroke